A Win For Carmell Therapeutics Corporation Class A Common Stock
Wed, Oct 16, 2024 at 07:48 PM
Carmell Therapeutics Corporation Class A Common Stock (CTCX:NASDAQ) jumped higher at $0.63, representing a gain of 67.6%. On Wed, Oct 16, 2024, CTCX:NASDAQ touched a New 2-Week High of $0.63. From Wed, Oct 02, 2024, the stock recorded 40.00% Up Days and 45.45% Green Days
The stock spiked on Wed, Oct 16, 2024 at $1.27 with a volume of 201M+.
About Carmell Therapeutics Corporation Class A Common Stock (CTCX:NASDAQ)
Alpha Healthcare Acquisition Corp III is a blank check company.
Top 10 Gainers:
- Reneo Pharmaceuticals Inc. (RPHM:NASDAQ), 952.02%
- Santech Holdings Ltd ADS (STEC:NASDAQ), 646.89%
- 180 Life Sciences Corp. (ATNF:NASDAQ), 325.66%
- Versus Systems Inc. (VS:NASDAQ), 249.56%
- VS Media Holdings Limited (VSME:NASDAQ), 128.87%
- ProQR Therapeutics N.V. (PRQR:NASDAQ), 122.1%
- Korro Bio, Inc. (KRRO:NASDAQ), 93.66%
- Wave Life Sciences Ltd. (WVE:NASDAQ), 74.07%
- Biodexa Pharmaceuticals plc Sponsored ADR (New) 2023 (BDRX:NASDAQ), 73.55%
- Carmell Therapeutics Corporation Class A Common Stock (CTCX:NASDAQ), 67.63%